Abiopharma

🔍 O CONNOR KEVIN J (Director)

Company: PROCORE TECHNOLOGIES, INC. (PCOR)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 2,530 shares of Common Stock at $50.62 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 994,222.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 3,239 shares of Common Stock at $51.42 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 990,983.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 5,565 shares of Common Stock at $53.34 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 985,418.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 204 shares of Common Stock at $54.07 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 985,214.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | shares_owned_after: 16,632.00

Footnotes:

• F1: These shares sold pursuant to a 10b5-1 plan dated November 21, 2024.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $50.15 to $51.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $51.21 to $51.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $52.78 to $53.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.